AP-1 complexes mediate oxidized LDL-induced overproduction of TGF-β1 in rat mesangial cells

Cell Biochemistry and Function

Volumn 22, Issue 4, 2004, Pages 237-247

  Wu, Zhaolong ^a,b   Zhou, Qin ^a   Lan, Yang ^a   Wang, Yuancheng ^a   Xu, Xunhui ^a   Jin, Huiming ^a  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Activator Protein Activating Protein 1; Glomerular mesangial cells; Oxidized low density lipoprotein; Signal transduction; Transforming growth factor

Indexed keywords

CELL DNA; CURCUMIN; LUCIFERASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; NUCLEAR PROTEIN; OLIGONUCLEOTIDE; OXIDIZED LOW DENSITY LIPOPROTEIN; TRANSCRIPTION FACTOR AP 1; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING ASSAY; BINDING SITE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DELETION MUTANT; DNA FLANKING REGION; GEL MOBILITY SHIFT ASSAY; GENE ACTIVATION; GENE ACTIVITY; GENE CONSTRUCT; GENE EXPRESSION REGULATION; GENE INDUCTION; GENE SEQUENCE; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; KIDNEY FIBROSIS; LIPID OXIDATION; MESANGIUM CELL; MUTAGENESIS; NEPHROSCLEROSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN LIPID INTERACTION; RAT; REPORTER GENE; TRANSCRIPTION REGULATION;

ANIMALS; BINDING SITES; CURCUMIN; GENE EXPRESSION REGULATION; GLOMERULAR MESANGIUM; HUMANS; LIPOPROTEINS, LDL; MALE; MUTAGENESIS, SITE-DIRECTED; NUCLEAR PROTEINS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROMOTER REGIONS, GENETIC; PROTEIN KINASE C; PROTO-ONCOGENE PROTEINS C-JUN; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT FUSION PROTEINS; REGULATORY SEQUENCES, NUCLEIC ACID; RNA, MESSENGER; SEQUENCE DELETION; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1; TRANSFORMING GROWTH FACTOR BETA1;

EID: 3142521635     PISSN: 02636484     EISSN: None     Source Type: Journal    
DOI: 10.1002/cbf.1096     Document Type: Article

References (41)

1. Wolf G, Ziyadeh FN. Molecular mechanisms of diabetic renal hypertrophy. Kidney Int 1999; 56: 393-405.
2. Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis. N Engl J Med 1994; 331: 1286-1292.
3. Cora W, Katrin B, Hans UH, Crambaro G, Schleidrer ED. Low-molecular-weight heparin prevents high glucose- and phorbol ester-induced TGF-β1 gene activation. Kidney Int 2001; 60: 935-943.
4. Wheeler DC, Chana RS, Topley N, Petersen MM, Dayies M, Williams JD. Oxidiation of low density lipoprotein by mesangial cells may promote glomerular injury. Kidney Int 1994; 45: 1628-1639.
5. Kirschenbaum MA, Pai R, Roh DD, Kamanna VS. Role of atherogenic lipoproteins in cytokine-mediated renovascular injury. Miner Electrol Metab 1996; 22: 47-50.
6. Ding GH, Goor HV, Ricardo SD, Orlowski JM, Diomond JR. Oxidized LDL stimulates the expression of TGF-β and fibronectin in human glomerular epithelial cells. Kidney Int 1997; 51: 147-154.
7. Karin M, Liu Z, Zandi E. AP-1 function and regulation. Curr Opin Cell Biol 1997; 9: 240-246.
8. Ares MPS, Kallin B, Eriksson P, Nilsson J. Oxidized LDL induces transcription factor activator protein-1 but inhibits activation of nuclear factor NF-κB in human vascular smooth muscle cells. Arteriosclerosis Thromb Vasc Biol 1995; 15: 1584-1590.
9. Zhu Y, Lin JHC, Liao HL, et al. LDL induces transcription factor activitor protein-1 in human endothelial cells. Arteriosclerosis Thromb Vasc Biol 1998; 18: 473-480.
10. Simonson MS, Dunn MJ. Eicosanoid biochemistry in cultured glomerular mesangial cells. Methods Enzymol 1990; 187: 544-553.
11. Haneda M, Kikkawa R, Maeda S. Dual mechanism of angiotensin II inhibits ANP-induced mesangial cGMP accumulation. Kidney Int 1991; 40: 188-194.
12. Ohisson BG, England MCO, Karisson ALK. Low density lipoprotein inhibits lipopolysaccharide-induced binding of nuclear factor-KB to DNA and the subsequent expression of tumor necrosis factor-α and interleukin-1β in macrophages. J Clin Invest 1996; 98: 78-89.
13. Chuen MY, Chi TC, Chuan CW, et al. Activation of mitogen-activated protein kinase by oxidized low density lipoprotein in canine cultured vascular smooth muscle cells. Cell Signal 2000; 12: 205-214.
14. Wu ZL, Liang MY, Qiu LQ. Oxidized low density lipoprotein decreases the induced nitric oxide synthesis in rat mesangial cells. Cell Biochem Funct 1998; 16: 153-158.
15. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265.
16. Andrews NC, Faller DV. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res 1991; 19: 2499-2501.
17. Smart DE, Vincent KJ, Arthur MJP, et al. JunD regulates transcription of the tissue inhibitor of metalloproteinases-1 and interleukin-6 gene in activated hepatic stellate cells. J Biol Chem 2001; 276: 24414-24421.
18. Manfred L, Andreas H, Wagner MC, Orzechowski HD, Hecker M. Transcriptional control of deformation-induced preproendothelin-1 gene expression in endothelial cells. J Mol Med 2000; 78: 441-450.
19. Wangner AS, Kezesz R, Gao DC, Schrdeder C, Cattaruzza M, Hecker M. Decoy oligodeoxynucleotide characterization of transcription factors controlling endothin-B receptor expression in vascular smooth muscle cells. Mol Pharmacol 2000; 58: 1333-1340.
20. Nesterova M, Yokozaki H, McDuffie E, Cho-Chung YS. Overexpression of RII beta regulatory subunit of protein kinase A in human colon carcinoma cell induces growth arrest and phenotypic changes that are abolished by site-directed mutation of RII beta. Eur J Biochem 1996; 235: 486-494.
21. Morishita R, Gibbons GH, Kaneda Y, Ogihara T, Dzau VJ. Novel and effective gene transfer technique for study of vascular renin angiotensin system. J Clin Invest 1993; 91: 2580-2585.
22. Karin M, Zheng GL, Ebrahim Z. AP-1 function and regulation. Curr Opin Cell Biol 1997; 9: 240-246.
23. Angel P, Karin M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta 1991; 1072: 129-157.
24. Mechta F, Yaniv M. Structure and regulation of the c-Jun promoter. In The Fos and Jun Families of Transcription Factors, Angel PE, Herrlich PA (eds). CRC Press Inc: Boca Raton, FL; 115-129.
25. Karin M. The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem 1995; 270: 16483-16486.
26. Derijard B, Hibi M, Wu I-H, et al. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 1994; 76: 1025-1037.
27. Kyriakis JM, Banerjee P, Nikolakaki E, et al. The stress-activated protein kinase subfamily of c-Jun kinases. Nature 1994; 369: 156-160.
28. Sanchez I, Hughes RT, Mayer BJ, et al. Role of SAPK/ERK kinase-1 in the stress-activated pathway regulating transcription factor c-Jun. Nature 1994; 372: 794-798.
29. Herr I, van Dam H, Angel P. Binding of promoter associated AP-1 is not altered during induction and subsequent repression of the c-Jun promoter by TPA and UV irradiation. Carcinogenesis 1994; 15: 1105-1113.
30. Kolch W, Heidecker G, Kochs G, et al. Protein kinase C alpha activates RAF-1 by direct phosphorylation. Nature 1993; 364: 249-252.
31. Sozeri O, Vollmer K, Liyanage M, et al. Activation of the c-Raf protein kinase by protein kinase C phosphorylation. Oncogene 1992; 7: 2259-2262.
32. Liu ZG, Hsu H, Goeddel DV, Karin M. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death. Cell 1996; 87: 565-576.
33. Zhu Y, Liao HL, Wang NP. Low-density lipoprotein activates Jun-N-terminal kinase (JNK) in human endothelial cells. Biochim Biophys Acta 1999; 1436: 557-564.
34. Isono M, Haneda M, Maeda S, Kanbe OK, Kikkawa R. Atrial natriuretic peptide inhibits endothelin-1-induced activation of JNK in glomerular mesangial cells. Kidney Int 1998; 53: 1133-1142.
35. Metzler B, Hu Y, Dietrich H, Xu Q. Increased expression and activation of stress-activated protein kinase/c-Jun NH(2)-terminal protein kinases in atherosclerotic lesions coincide with p53. Am J Pathol 2000; 156: 1875-1886.
36. Morishita R, Higaki J, Tomita N, et al. Role of transcriptional cis-elements, angiotensinogen gene-activating elements, of angiotensinogen gene in blood pressure regulation. Hypertension 1996; 27: 502-507.
37. Yoon SCC, Yun GP, Maria N, Lee YN, Cho YS. CRE-decoy oligonucleotide- inhibition of gene expression and tumor growth. Mol Cell Biochem 2000; 212: 29-34.
38. Yun GP, Maria N, Sudhir A, Cho-Chung YS. Dual blockade of cyclic AMP response element-(CRE) and AP-1-directed transcription by CRE-transcription factor decoy oligonucleotide. J Biol Chem 1999; 274: 1573-1580.
39. Sharma K, Jin Y, Guo J, Ziyadeh FN. Neutralizafion of TGF-beta by anti-TGF-beta antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice. Diabetes 1996; 45: 522-530.
40. Ziyadeh FN, Hoffman BB, Han DC, et al. Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-β antibody in db/ db diabetic mice. Proc Natl Acad Sci USA 2000; 97: 8015-8020.
41. Wu ZL, Wang YC, Zhou Q, Ge YQ, Lan Y. Oxidized LDL induces transcription factor activator protein-1 in rat mesangial cells. Cell Biochem Funct 2003; 21: 249-256.